Market Exclusive

Analyst Activity – Guggenheim Reiterates Buy on NASDAQ:MNLO – Menlo Therapeutics (NASDAQ:MNLO)

Analyst Ratings For NASDAQ:MNLO – Menlo Therapeutics (NASDAQ:MNLO)

Today, Guggenheim reiterated its Buy rating on NASDAQ:MNLO – Menlo Therapeutics (NASDAQ:MNLO) with a price target of $11.00.

Some recent analyst ratings include


Recent Trading Activity for NASDAQ:MNLO – Menlo Therapeutics (NASDAQ:MNLO)
Shares of NASDAQ:MNLO – Menlo Therapeutics closed the previous trading session at 7.41 down -0.60 7.50% with 6.989999771118164 shares trading hands.

Exit mobile version